Dr. John Carlo said it was too good to be true. For a decade, health clinics like the five he runs in the Dallas area had come to rely on Gilead Science’s patient assistance program to help pay for their HIV and AIDS services. But last year, the pharmaceutical giant made a decision that blocked funds for services unrelated to …
Read More »HIV clinics take hit after pharm giant ends funds for services unrelated to PrEP purchases
February 15, 2023